Cargando…
The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
The specificity of prostate-specific antigen (PSA) for early intervention in repeat biopsy is unsatisfactory. Prostate cancer antigen 3 (PCA3) may be more accurate in outcome prediction than other methods for the early detection of prostate cancer (PCa). However, the results were inconsistent in rep...
Autores principales: | Luo, Yong, Gou, Xin, Huang, Peng, Mou, Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023384/ https://www.ncbi.nlm.nih.gov/pubmed/24713827 http://dx.doi.org/10.4103/1008-682X.125390 |
Ejemplares similares
-
PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013) -
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015) -
Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
por: Agnihotri, Shalini, et al.
Publicado: (2014) -
MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
por: Tosoian, Jeffrey J., et al.
Publicado: (2022) -
Cut-Off Scores of an Olfactory Function Test for Mild Cognitive Impairment and Dementia
por: Kim, Hye Ri, et al.
Publicado: (2020)